How many drugs treat Thyroid eye disease?

Drug Landscape tracks 2 marketed treatments for Thyroid eye disease (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/thyroid-eye-disease.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Thyroid eye disease — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thyroid eye disease (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Thyroid eye disease, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Tepezza	TEPROTUMUMAB	Horizon Therapeutics Ireland	Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]	IGF-1R		2020-01-01
TEPEZZA	TEPROTUMUMAB-TRBW	HORIZON THERAPEUTICS IRELAND	Insulin-like Growth Factor-1 Receptor Inhibitor [EPC]	Insulin-like growth factor 1 receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

HORIZON THERAPEUTICS IRELAND · 1 drug in Thyroid eye disease
Horizon Therapeutics Ireland · 1 drug in Thyroid eye disease

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Thyroid eye disease:

Cite this brief

Drug Landscape (2026). Thyroid eye disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/thyroid-eye-disease. Accessed 2026-06-10.

Thyroid eye disease full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing